Cargando…
Long non-coding RNA DDX11-AS1 promotes the proliferation and migration of glioma cells by combining with HNRNPC
Glioma is a malignant tumor of the central nervous system with complex pathogenesis, difficult operation, and a high postoperative recurrence rate. At present, there is still a lack of effective treatment. Long non-coding RNA DDX11 antisense RNA 1 (DDX11-AS1) has been shown to promote tumor developm...
Autores principales: | Xiang, Zijin, Lv, Qiaoli, Zhang, Yujun, Chen, Xueru, Guo, Ren, Liu, Shikun, Peng, Xiangdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109126/ https://www.ncbi.nlm.nih.gov/pubmed/35614994 http://dx.doi.org/10.1016/j.omtn.2022.04.016 |
Ejemplares similares
-
Lnc GNG12-AS1 knockdown suppresses glioma progression through the AKT/GSK-3β/β-catenin pathway
por: Xiang, Zijin, et al.
Publicado: (2020) -
A Novel Inflammatory lncRNAs Prognostic Signature for Predicting the Prognosis of Low-Grade Glioma Patients
por: Xiang, Zijin, et al.
Publicado: (2021) -
ACTL6A knockdown inhibits cell migration by suppressing the AKT signaling pathway and enhances the sensitivity of glioma cells to temozolomide
por: Chen, Xueru, et al.
Publicado: (2021) -
HNRNPC Promotes Proliferation, Metastasis and Predicts Prognosis in Prostate Cancer
por: Wang, Shiyu, et al.
Publicado: (2021) -
Identification and Validation of an Endoplasmic Reticulum Stress-Related lncRNA Signature for Colon Adenocarcinoma Patients
por: Chen, Xueru, et al.
Publicado: (2022)